The Europe blood market is predicted to grow with a CAGR of 3.82%, across the forecast period of 2019 to 2028. The presence of numerous key players in the region and the prevalence of chronic diseases that require blood and its components’ transfusions for treatment drive the market growth. The Europe blood market growth is determined by analyzing the United Kingdom, Poland, Germany, Belgium, France, Russia, Italy, and the rest of Europe.

EUROPE BLOOD MARKET FORECAST 2019-2028

Europe Blood Market by Product (Whole Blood Collection (Whole Blood Collection Systems, Whole Blood Collection Reagents), Source Plasma Collection (Source Plasma Collection Systems, Source Plasma Collection Reagents), Blood Therapeutics (Intravenous Immunoglobulin (Ivig),albumin, Hyperimmune, Factor Viii, Factor Ix, Other Blood Therapeutics), Blood Typing (Blood Typing Systems, Blood Typing Reagents), Blood Screening (Blood Screening Systems, Blood Screening Reagents), Blood Processing Equipment (Blood Processing Equipment Systems, Blood Processing Equipment Reagents)) by End-user (Blood & Blood Component Banks, Diagnostic Laboratories, Ambulatory Surgical Centers, Hospitals, Other End-users) and by Geography.

Request free sample

The Europe blood market is predicted to grow with a CAGR of 3.82%, across the forecast period of 2019 to 2028. The presence of numerous key players in the region and the prevalence of chronic diseases that require blood and its components’ transfusions for treatment drive the market growth.
Europe Blood Market

To know more about this report, request a free sample copy

The Europe blood market growth is determined by analyzing the United Kingdom, Poland, Germany, Belgium, France, Russia, Italy, and the rest of Europe. The United Kingdom’s blood market observes a stabilized growth rate, which is attributed to the presence of major key players. The country has four primary blood transfusion services, named, the Scottish National Blood Transfusion (SNBTS), NHS Blood and Transplant (NHSBT), the Northern Ireland Blood Transfusion Service (NIBTS), and the Welsh Blood Service (WBS), that sustain the region’s market growth.

Moreover, laboratory tests are continually rising in the United Kingdom’s healthcare. Over 50% of tests ordered by general practitioners examine chronic ailments like diabetes, chronic kidney disease, and hypertension. Other aspects that drive the market growth include, a surge in the geriatric population and the rise in laboratory tests in the healthcare sector. The elderly are highly vulnerable to different illnesses that require blood and plasma for treatments. Conversely, the tests ordered by general physician practices, monitor chronic and long-term ailments like hypertension, kidney diseases, and diabetes. These factors are instrumental in driving the region’s market growth.

Novo Nordisk, headquartered in Denmark, is a global healthcare enterprise that distributes diabetes and obesity-care products. The company also holds a leadership status in hemophilia, hormone replacement therapy, and growth hormone therapy. In February 2020, it announced the launch of Espercot, for the treatment and prevention of bleeding in patients suffering from Hemophilia A.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      • MARKET DEFINITION
      •    KEY DRIVERS
        • INCREASING DEMAND FOR BLOOD AND OTHER BLOOD RELATED PRODUCTS ACROSS THE WORLD
        • SURGE IN GERIATRIC POPULATION ACROSS THE GLOBE
        • RISE IN BLOOD DONATIONS AND PLASMA DONATIONS
        • PROMISING GOVERNMENT REGULATIONS FOR BLOOD SCREENING
        • PROGRESSION IN BLOOD TRANSFUSION AND BLOOD SCREENING INSTRUMENTS
      •    KEY RESTRAINTS
        • HIGH COST OF ADVANCED BLOOD COLLECTION DEVICES
        • DEARTH OF SKILLED LABORATORY PROFESSIONALS
    1. KEY ANALYTICS
      • KEY INVESTMENT INSIGHTS
      •    PORTER’S FIVE FORCE ANALYSIS
        • BUYER POWER
        • SUPPLIER POWER
        • SUBSTITUTION
        • NEW ENTRANTS
        • INDUSTRY RIVALRY
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
      • IMPACT OF COVID – BLOOD MARKET
    2. MARKET BY PRODUCT
      •    WHOLE BLOOD COLLECTION
        • WHOLE BLOOD COLLECTION SYSTEMS
        • WHOLE BLOOD COLLECTION REAGENTS
      •    SOURCE PLASMA COLLECTION
        • SOURCE PLASMA COLLECTION SYSTEMS
        • SOURCE PLASMA COLLECTION REAGENTS
      •    BLOOD THERAPEUTICS
        • INTRAVENOUS IMMUNOGLOBULIN (IVIG)
        • ALBUMIN
        • HYPERIMMUNE
        • FACTOR VIII
        • FACTOR IX
        • OTHER BLOOD THERAPEUTICS
      •    BLOOD TYPING
        • BLOOD TYPING SYSTEMS
        • BLOOD TYPING REAGENTS
      •    BLOOD SCREENING
        • BLOOD SCREENING SYSTEMS
        • BLOOD SCREENING REAGENTS
      •    BLOOD PROCESSING EQUIPMENT
        • BLOOD PROCESSING EQUIPMENT SYSTEMS
        • BLOOD PROCESSING EQUIPMENT REAGENTS
    1. MARKET BY END-USER
      • BLOOD & BLOOD COMPONENT BANKS
      • DIAGNOSTIC LABORATORIES
      • AMBULATORY SURGICAL CENTERS
      • HOSPITALS
      • OTHER END-USERS
    2. GEOGRAPHICAL ANALYSIS
      •    EUROPE
        • UNITED KINGDOM
        • GERMANY
        • FRANCE
        • ITALY
        • RUSSIA
        • BELGIUM
        • POLAND
        • REST OF EUROPE
    1. COMPANY PROFILES
      • ABBOTT LABORATORIES
      • BIO-RAD LABORATORIES INC
      • CSL LIMITED (CSL BEHRING)
      • F HOFFMANN-LA ROCHE LTD
      • GRIFOLS INTERNATIONAL SA
      • HAEMONETICS CORPORATION
      • MERCK & CO INC
      • NOVO NORDISK A/S
      • BAXTER INTERNATIONAL INC
      • BECTON, DICKINSON AND COMPANY
      • FRESENIUS KABI AG
      • ORTHO CLINICAL DIAGNOSTICS
      • TERUMO CORPORATION (TERUMO BCT INC)
      • IMMUCOR INC

    LIST OF TABLES

    TABLE 1: MARKET SNAPSHOT – BLOOD

    TABLE 2: EUROPE BLOOD MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

    TABLE 3: EUROPE BLOOD MARKET, BY PRODUCT, FORECAST YEARS, 2019-2028 (IN $ MILLION)

    TABLE 4: EUROPE BLOOD MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

    TABLE 5: EUROPE BLOOD MARKET, BY END-USER, FORECAST YEARS, 2019-2028 (IN $ MILLION)

    TABLE 6: EUROPE BLOOD MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

    TABLE 7: EUROPE BLOOD MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

    LIST OF FIGURES

    FIGURE 1: KEY INVESTMENT INSIGHTS

    FIGURE 2: PORTER’S FIVE FORCE ANALYSIS

    FIGURE 3: OPPORTUNITY MATRIX

    FIGURE 4: VENDOR LANDSCAPE

    FIGURE 5: EUROPE BLOOD MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2019

    FIGURE 6: EUROPE BLOOD MARKET, BY WHOLE BLOOD COLLECTION, 2019-2028 (IN $ MILLION)

    FIGURE 7: EUROPE BLOOD MARKET, GROWTH POTENTIAL, BY WHOLE BLOOD COLLECTION, IN 2019

    FIGURE 8: EUROPE BLOOD MARKET, BY WHOLE BLOOD COLLECTION SYSTEMS, 2019-2028 (IN $ MILLION)

    FIGURE 9: EUROPE BLOOD MARKET, BY WHOLE BLOOD COLLECTION REAGENTS, 2019-2028 (IN $ MILLION)

    FIGURE 10: EUROPE BLOOD MARKET, BY SOURCE PLASMA COLLECTION, 2019-2028 (IN $ MILLION)

    FIGURE 11: EUROPE BLOOD MARKET, GROWTH POTENTIAL, BY SOURCE PLASMA COLLECTION, IN 2019

    FIGURE 12: EUROPE BLOOD MARKET, BY SOURCE PLASMA COLLECTION SYSTEMS, 2019-2028 (IN $ MILLION)

    FIGURE 13: EUROPE BLOOD MARKET, BY SOURCE PLASMA COLLECTION REAGENTS, 2019-2028 (IN $ MILLION)

    FIGURE 14: EUROPE BLOOD MARKET, BY BLOOD THERAPEUTICS, 2019-2028 (IN $ MILLION)

    FIGURE 15: EUROPE BLOOD MARKET, GROWTH POTENTIAL, BY BLOOD THERAPEUTICS, IN 2019

    FIGURE 16: EUROPE BLOOD MARKET, BY SOURCE PLASMA COLLECTION SYSTEMS, 2019-2028 (IN $ MILLION)

    FIGURE 17: EUROPE BLOOD MARKET, BY ALBUMIN, 2019-2028 (IN $ MILLION)

    FIGURE 18: EUROPE BLOOD MARKET, BY HYPERIMMUNE, 2019-2028 (IN $ MILLION)

    FIGURE 19: EUROPE BLOOD MARKET, BY FACTOR VIII, 2019-2028 (IN $ MILLION)

    FIGURE 20: EUROPE BLOOD MARKET, BY FACTOR IX, 2019-2028 (IN $ MILLION)

    FIGURE 21: EUROPE BLOOD MARKET, BY OTHER BLOOD THERAPEUTICS, 2019-2028 (IN $ MILLION)

    FIGURE 22: EUROPE BLOOD MARKET, BY BLOOD TYPING, 2019-2028 (IN $ MILLION)

    FIGURE 23: EUROPE BLOOD MARKET, GROWTH POTENTIAL, BY BLOOD TYPING, IN 2019

    FIGURE 24: EUROPE BLOOD MARKET, BY BLOOD TYPING SYSTEMS, 2019-2028 (IN $ MILLION)

    FIGURE 25: EUROPE BLOOD MARKET, BY BLOOD TYPING REAGENTS, 2019-2028 (IN $ MILLION)

    FIGURE 26: EUROPE BLOOD MARKET, BY BLOOD SCREENING, 2019-2028 (IN $ MILLION)

    FIGURE 27: EUROPE BLOOD MARKET, GROWTH POTENTIAL, BY BLOOD SCREENING, IN 2019

    FIGURE 28: EUROPE BLOOD MARKET, BY BLOOD SCREENING SYSTEMS, 2019-2028 (IN $ MILLION)

    FIGURE 29: EUROPE BLOOD MARKET, BY BLOOD SCREENING REAGENTS, 2019-2028 (IN $ MILLION)

    FIGURE 30: EUROPE BLOOD MARKET, BY BLOOD PROCESSING EQUIPMENT, 2019-2028 (IN $ MILLION)

    FIGURE 31: EUROPE BLOOD MARKET, GROWTH POTENTIAL, BY BLOOD PROCESSING EQUIPMENT, IN 2019

    FIGURE 32: EUROPE BLOOD MARKET, BY BLOOD PROCESSING EQUIPMENT SYSTEMS, 2019-2028 (IN $ MILLION)

    FIGURE 33: EUROPE BLOOD MARKET, BY BLOOD PROCESSING EQUIPMENT REAGENTS, 2019-2028 (IN $ MILLION)

    FIGURE 34: EUROPE BLOOD MARKET, GROWTH POTENTIAL, BY END-USER, IN 2019

    FIGURE 35: EUROPE BLOOD MARKET, BY BLOOD & BLOOD COMPONENT BANKS, 2019-2028 (IN $ MILLION)

    FIGURE 36: EUROPE BLOOD MARKET, BY DIAGNOSTIC LABORATORIES, 2019-2028 (IN $ MILLION)

    FIGURE 37: EUROPE BLOOD MARKET, BY AMBULATORY SURGICAL CENTERS, 2019-2028 (IN $ MILLION)

    FIGURE 38: EUROPE BLOOD MARKET, BY HOSPITALS, 2019-2028 (IN $ MILLION)

    FIGURE 39: EUROPE BLOOD MARKET, BY OTHER END-USERS, 2019-2028 (IN $ MILLION)

    FIGURE 40: EUROPE BLOOD MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)

    FIGURE 41: UNITED KINGDOM BLOOD MARKET, 2019-2028 (IN $ MILLION)

    FIGURE 42: GERMANY BLOOD MARKET, 2019-2028 (IN $ MILLION)

    FIGURE 43: FRANCE BLOOD MARKET, 2019-2028 (IN $ MILLION)

    FIGURE 44: ITALY BLOOD MARKET, 2019-2028 (IN $ MILLION)

    FIGURE 45: RUSSIA BLOOD MARKET, 2019-2028 (IN $ MILLION)

    FIGURE 46: BELGIUM BLOOD MARKET, 2019-2028 (IN $ MILLION)

    FIGURE 47: POLAND BLOOD MARKET, 2019-2028 (IN $ MILLION)

    FIGURE 48: REST OF EUROPE BLOOD MARKET, 2019-2028 (IN $ MILLION)

    1. GEOGRAPHICAL ANALYSIS
      •    EUROPE
        • UNITED KINGDOM
        • GERMANY
        • FRANCE
        • ITALY
        • RUSSIA
        • BELGIUM
        • POLAND
        • REST OF EUROPE
    1. MARKET BY PRODUCT
      •    WHOLE BLOOD COLLECTION
        • WHOLE BLOOD COLLECTION SYSTEMS
        • WHOLE BLOOD COLLECTION REAGENTS
      •    SOURCE PLASMA COLLECTION
        • SOURCE PLASMA COLLECTION SYSTEMS
        • SOURCE PLASMA COLLECTION REAGENTS
      •    BLOOD THERAPEUTICS
        • INTRAVENOUS IMMUNOGLOBULIN (IVIG)
        • ALBUMIN
        • HYPERIMMUNE
        • FACTOR VIII
        • FACTOR IX
        • OTHER BLOOD THERAPEUTICS
      •    BLOOD TYPING
        • BLOOD TYPING SYSTEMS
        • BLOOD TYPING REAGENTS
      •    BLOOD SCREENING
        • BLOOD SCREENING SYSTEMS
        • BLOOD SCREENING REAGENTS
      •    BLOOD PROCESSING EQUIPMENT
        • BLOOD PROCESSING EQUIPMENT SYSTEMS
        • BLOOD PROCESSING EQUIPMENT REAGENTS
    1. MARKET BY END-USER
      • BLOOD & BLOOD COMPONENT BANKS
      • DIAGNOSTIC LABORATORIES
      • AMBULATORY SURGICAL CENTERS
      • HOSPITALS
      • OTHER END-USERS

    To request a free sample copy of this report, please complete the form below :
    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

      Choose License Type